- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2015
- Public Summary Document (PSD) March 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2015 PBAC Meeting - Word
Ruxolitinib – March 2015
Ruxolitinib; 5 mg tablet 56, 15 mg tablet 56, 20 mg tablet 56; Jakavi®
Last updated
3 July 2015